These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improved cytosolic free calcium mobilization and superoxide production in bicarbonate-based peritoneal dialysis solution. Dobos GJ; Burger M; Kuhlmann J; Passlick-Deetjen J; Schollmeyer P; Böhler J Nephrol Dial Transplant; 1997 May; 12(5):973-7. PubMed ID: 9175052 [TBL] [Abstract][Full Text] [Related]
5. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. Schambye HT; Pedersen FB; Wang P Adv Perit Dial; 1992; 8():42-6. PubMed ID: 1361838 [TBL] [Abstract][Full Text] [Related]
6. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Liberek T; Topley N; Jörres A; Petersen MM; Coles GA; Gahl GM; Williams JD Nephron; 1993; 65(2):260-5. PubMed ID: 8247190 [TBL] [Abstract][Full Text] [Related]
7. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. Liberek T; Topley N; Jörres A; Coles GA; Gahl GM; Williams JD J Am Soc Nephrol; 1993 Feb; 3(8):1508-15. PubMed ID: 8387831 [TBL] [Abstract][Full Text] [Related]
8. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios. Schambye HT; Pedersen FB; Christensen HK; Berthelsen H; Wang P Perit Dial Int; 1993; 13 Suppl 2():S116-8. PubMed ID: 8399544 [TBL] [Abstract][Full Text] [Related]
9. [Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts]. Soria M; Arrieta J; Ugarte I; Moina I; Guerra M; Escanero J Nefrologia; 2004; 24(2):158-66. PubMed ID: 15219091 [TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113 [TBL] [Abstract][Full Text] [Related]
11. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184 [TBL] [Abstract][Full Text] [Related]
12. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. Topley N; Kaur D; Petersen MM; Jörres A; Williams JD; Faict D; Holmes CJ J Am Soc Nephrol; 1996 Feb; 7(2):218-24. PubMed ID: 8785390 [TBL] [Abstract][Full Text] [Related]
13. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. van Bronswijk H; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Verhoef J Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):368-73. PubMed ID: 3137037 [TBL] [Abstract][Full Text] [Related]
14. Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. Jörres A; Jörres D; Topley N; Gahl GM; Mahiout A Nephrol Dial Transplant; 1991; 6(7):495-501. PubMed ID: 1922911 [TBL] [Abstract][Full Text] [Related]
15. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. Thomas S; Schenk U; Fischer FP; Mettang T; Passlick-Deetjen J; Kuhlmann U Am J Kidney Dis; 1997 Feb; 29(2):246-53. PubMed ID: 9016897 [TBL] [Abstract][Full Text] [Related]
16. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498 [TBL] [Abstract][Full Text] [Related]
17. The effect of dialysate glucose on phagocyte superoxide generation in CAPD patients. Kashem A; Nomoto Y; Tanabe R; Nishina M; Endoh H; Nakajima K; Endoh M; Sakai H; Nakazawa H Perit Dial Int; 1998; 18(1):52-9. PubMed ID: 9527030 [TBL] [Abstract][Full Text] [Related]
18. Effect of different buffers on the biocompatibility of CAPD solutions. Schambye HT Perit Dial Int; 1996; 16 Suppl 1():S130-6. PubMed ID: 8728179 [TBL] [Abstract][Full Text] [Related]
19. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Alobaidi HM; Coles GA; Davies M; Lloyd D Nephrol Dial Transplant; 1986; 1(1):16-21. PubMed ID: 3110659 [TBL] [Abstract][Full Text] [Related]
20. Neutrophilic transient acidification and superoxide production in peritoneal dialysate. Zhou FQ; Zhou XJ; Yu AW; Song RH Chin Med Sci J; 1999 Dec; 14(4):215-9. PubMed ID: 12894894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]